News Trump gives pharma ultimatum on most favoured nation pricing President Trump has given 17 pharma companies until 29th September to commit to providing lower prices "to every single Medicaid patient."
Patients The unexpected starting line: Solving drug affordability at ... In early 2025, the White House renewed its push to lower prescription drug prices, part of an executive order aimed at easing patients' financial burdens.
News Makary, Prasad set out their vision for the FDA Top FDA officials have spelled out their strategic priorities in the coming years, including the use of AI to "increase efficiency."
News First details of Trump's most favoured nation plan emerge Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he first said it would be.
News Update: Trump 'will tie US drug prices to other countries' President Donald Trump said he will sign an order today to cut prescription drug prices in the US to the level paid by other comparable countries.
News Spectre of 'favoured nation' pricing manifests again in US President Trump is rumoured to be resurrecting a policy that would see drug prices offered to federal programmes tied to those offered overseas.
R&D LSX2026: On a therapeutic vision for ocular disease, with Al... Alexander Gebauer, co-founder & executive chairman of Galimedix Therapeutics, discusses transforming treatment of major neurodegenerative eye diseases
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.